CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 5. Cell surface expression of differentiation marker CD41. Wild-type K562 cells and the mutant clones were treated with DMSO or PMA for 6 days before collection. Cells were stained with the control antibody ZPO-1 or with antibodies directed against CD41 and CD61. Bound antibody was detected with FITC-conjugated goat antimouse antibody. Histograms of the fluorescence intensity are reported for wild-type cells and for mutant clones C1 and C4.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation